ENDRA LIFE SCIENCES INC. Proceeds from Sales of Assets, Investing Activities
ENDRA LIFE SCIENCES INC. (NDRA) reported Proceeds from Sales of Assets, Investing Activities of $3.20 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSalesOfAssetsInvestingActivities · last filed 2026-03-31
- ENDRA LIFE SCIENCES INC. proceeds from sales of assets, investing activities for the quarter ending 2024-12-31 was $0.00.
- ENDRA LIFE SCIENCES INC. proceeds from sales of assets, investing activities for fiscal 2024 was $3.20K.
| Period end | Proceeds from Sales of Assets, Investing Activities 3 month | Proceeds from Sales of Assets, Investing Activities 9 month | Proceeds from Sales of Assets, Investing Activities 12 month |
|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $3.20K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $3.20K 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |